Walleye Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $741K | Sell |
136,000
-97,600
| -42% | -$548K | ﹤0.01% | 2328 |
|
|
2025
Q4 | $1.64M | Buy |
233,600
+104,400
| +81% | +$817K | ﹤0.01% | 2040 |
|
|
2025
Q3 | $999K | Buy |
129,200
+38,700
| +43% | +$302K | ﹤0.01% | 2274 |
|
|
2025
Q2 | $788K | Buy |
90,500
+7,500
| +9% | +$54.4K | ﹤0.01% | 2351 |
|
|
2025
Q1 | $661K | Sell |
83,000
-14,000
| -14% | -$142K | ﹤0.01% | 2342 |
|
|
2024
Q4 | $882K | Buy |
97,000
+71,400
| +279% | +$689K | ﹤0.01% | 2246 |
|
|
2024
Q3 | $235K | Buy |
25,600
+2,000
| +8% | +$16.6K | ﹤0.01% | 2969 |
|
|
2024
Q2 | $231K | Sell |
23,600
-71,300
| -75% | -$870K | ﹤0.01% | 3002 |
|
|
2024
Q1 | $1.43M | Sell |
94,900
-123,100
| -56% | -$2.23M | ﹤0.01% | 1954 |
|
|
2023
Q4 | $4.7M | Buy |
218,000
+15,300
| +8% | +$282K | 0.01% | 1291 |
|
|
2023
Q3 | $3.77M | Sell |
202,700
-34,300
| -14% | -$801K | 0.01% | 1306 |
|
|
2023
Q2 | $6M | Buy |
237,000
+38,400
| +19% | +$966K | 0.02% | 844 |
|
|
2023
Q1 | $5.14M | Buy |
198,600
+23,700
| +14% | +$634K | 0.01% | 1025 |
|
|
2022
Q4 | $4.14M | Sell |
174,900
-5,100
| -3% | -$138K | 0.01% | 1185 |
|
|
2022
Q3 | $4.56M | Sell |
180,000
-3,000
| -2% | -$105K | 0.01% | 1095 |
|
|
2022
Q2 | $6.08M | Sell |
183,000
-310,700
| -63% | -$13.2M | 0.02% | 902 |
|
|
2022
Q1 | $35.6M | Sell |
493,700
-301,800
| -38% | -$21.7M | 0.11% | 159 |
|
|
2021
Q4 | $73M | Buy |
795,500
+100,600
| +14% | +$12M | 0.24% | 70 |
|
|
2021
Q3 | $88.1M | Buy |
694,900
+237,100
| +52% | +$34.5M | 0.32% | 38 |
|
|
2021
Q2 | $76.1M | Buy |
457,800
+308,900
| +207% | +$50.1M | 0.3% | 41 |
|
|
2021
Q1 | $27.1M | Buy |
148,900
+31,100
| +26% | +$7.21M | 0.12% | 110 |
|
|
2020
Q4 | $23.6M | Buy |
117,800
+70,100
| +147% | +$14.3M | 0.1% | 134 |
|
|
2020
Q3 | $10.5M | Buy |
47,700
+8,600
| +22% | +$1.82M | 0.06% | 271 |
|
|
2020
Q2 | $7.46M | Buy |
39,100
+19,600
| +101% | +$3.43M | 0.05% | 378 |
|
|
2020
Q1 | $3.02M | Sell |
19,500
-7,600
| -28% | -$884K | 0.02% | 605 |
|
|
2019
Q4 | $2.27M | Sell |
27,100
-87,400
| -76% | -$6.65M | 0.02% | 1135 |
|
|
2019
Q3 | $7.75M | Buy |
114,500
+15,600
| +16% | +$1.03M | 0.07% | 286 |
|
|
2019
Q2 | $6.57M | Buy |
98,900
+43,200
| +78% | +$2.52M | 0.06% | 329 |
|
|
2019
Q1 | $3.1M | Sell |
55,700
-1,500
| -3% | -$91.6K | 0.02% | 770 |
|
|
2018
Q4 | $2.83M | Buy |
57,200
+52,000
| +1,000% | +$3.18M | 0.02% | 806 |
|
|
2018
Q3 | $449K | Buy |
+5,200
| New | +$371K | ﹤0.01% | 3007 |
|
Other funds holding TDOC
VPM
VCM
VC
Walleye Trading's TDOC Position: Q1 2026 in Review
Walleye Trading increased its Teladoc Health (TDOC) stake by 18% in Q1 2026, buying an estimated $199K and bringing the position to 233,646 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.
Walleye Trading first reported a position in TDOC in Q3 2016 and has held it in 21 quarters since. The position peaked at $75.7M in Q4 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Walleye Trading held 233,646 shares of Teladoc Health worth $1.27M as of Q1 2026.
- Walleye Trading bought 35,413 Teladoc Health shares in Q1 2026, an estimated $199K.
- Teladoc Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1994 holding.
- Walleye Trading first reported a position in Teladoc Health in Q3 2016 and has held it in 21 quarters since.
- Walleye Trading's Teladoc Health position peaked at $75.7M in Q4 2021.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.